Replies to post #107590 on Biotech Values

[DewDiligence]

Re: Authorized generic

…sanofi is sending all the signals that it is not looking to launch a AG, so long as there are only two competing products.

The evidence is now stronger than a mere signal. On SNY’s 3Q10 CC last week, COO Hanspeter Spek flat-out asserted that there will be no authorized generic as long as NVS/MNTA have the sole approved generic.

Thus, the implicit evidence from #msg-53738652 is now explicit.